Search

Your search keyword '"Sidorenkov, Grigory"' showing total 277 results
Start Over Author "Sidorenkov, Grigory"
277 results on '"Sidorenkov, Grigory"'

7. Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial

Author

Sidorenkov, Grigory, Stadhouders, Ralph, Jacobs, Colin, Mohamed Hoesein, Firdaus A.A., Gietema, Hester A., Nackaerts, Kristiaan, Saghir, Zaigham, Heuvelmans, Marjolein A., Donker, Hylke C., Aerts, Joachim G., Vermeulen, Roel, Uitterlinden, Andre, Lenters, Virissa, van Rooij, Jeroen, Schaefer-Prokop, Cornelia, Groen, Harry J.M., de Jong, Pim A., Cornelissen, Robin, Prokop, Mathias, de Bock, Geertruida H., and Vliegenthart, Rozemarijn

Published
2023
Full Text
View/download PDF

16. The relation of fat and muscle to emphysema and bronchial wall thickening in smokers

Author

Bunk, Stijn A.O., primary, Ipema, Jetty, additional, Sidorenkov, Grigory, additional, Bennink, Edwin, additional, Vliegenthart, Rozemarijn, additional, de Jong, Pim A., additional, Pompe, Esther, additional, Charbonnier, Jean-Paul, additional, Luijk, Bart H.D., additional, Aerts, Joachim, additional, Groen, Harry J.M., additional, and Mohamed Hoesein, Firdaus A.A., additional

Published
2024
Full Text
View/download PDF

17. Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population : rationale and design of the ImaLife (Imaging in Lifelines) Study

Author

Xia, Congying, Rook, Mieneke, Pelgrim, Gert Jan, Sidorenkov, Grigory, Wisselink, Hendrik J., van Bolhuis, Jurjen N., van Ooijen, Peter M. A., Guo, Jiapan, Oudkerk, Matthijs, Groen, Harry, van den Berge, Maarten, van der Harst, Pim, Dijkstra, Hildebrand, Vonder, Marleen, Heuvelmans, Marjolein A., Dorrius, Monique D., De Deyn, Peter Paul, de Bock, Geertruida H., Dotinga, Aafje, and Vliegenthart, Rozemarijn

Published
2020

24. Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Author

Weber, Sabrina, van der Leest, Paul, Donker, Hylke C., Schlange, Thomas, Timens, Wim, Tamminga, Menno, Hasenleithner, Samantha O., Graf, Ricarda, Moser, Tina, Spiegl, Benjamin, Yaspo, Marie-Laure, Terstappen, Leon W. M. M., Sidorenkov, Grigory, Hiltermann, T. Jeroen. N., Speicher, Michael R., Schuuring, Ed, Heitzer, Ellen, and Groen, Harry J. M.

Published
2021
Full Text
View/download PDF

30. Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients

Author

Rutgers, Abraham, primary, Westerweel, Peter E., additional, van der Holt, Bronno, additional, Postma, Simone, additional, van Vonderen, Marit G. A., additional, Piersma, Djura P., additional, Postma, Douwe, additional, van den Berge, Maarten, additional, Jong, Eefje, additional, de Vries, Marten, additional, van der Burg, Leonie, additional, Huugen, Dennis, additional, van der Poel, Marjolein, additional, Kampschreur, Linda M., additional, Nijland, Marcel, additional, Strijbos, Jaap H., additional, Tamminga, Menno, additional, Mutsaers, Pim G. N. J., additional, Schol-Gelok, Suzanne, additional, Dijkstra-Tiekstra, Margriet, additional, Sidorenkov, Grigory, additional, Vincenten, Julien, additional, van Geffen, Wouter H., additional, Knoester, Marjolein, additional, Kosterink, Jos, additional, Gans, Reinold, additional, Stegeman, Coen, additional, Huls, Gerwin, additional, and van Meerten, Tom, additional

Published
2022
Full Text
View/download PDF

31. Sex-Specific Cut-Off Values for Low Skeletal Muscle Mass to Identify Patients at Risk for Treatment-Related Adverse Events in Head and Neck Cancer

Author

Zwart, Aniek T., primary, Pörtzgen, Wolf, additional, van Rijn-Dekker, Irene, additional, Sidorenkov, Grigory A., additional, Dierckx, Rudi A. J. O., additional, Steenbakkers, Roel J. H. M., additional, Wegner, Inge, additional, van der Hoorn, Anouk, additional, de Bock, Geertruida H., additional, and Halmos, Gyorgy B., additional

Published
2022
Full Text
View/download PDF

33. Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling

Author

van der Leest, Paul, primary, Ketelaar, Emma M, additional, van Noesel, Carel J M, additional, van den Broek, Daan, additional, van Boerdonk, Robert A A, additional, Deiman, Birgit, additional, Rifaela, Naomi, additional, van der Geize, Robert, additional, Huijsmans, Cornelis J J, additional, Speel, Ernst Jan M, additional, Geerlings, Maartje J, additional, van Schaik, Ron H N, additional, Jansen, Maurice P H M, additional, Dane-Vogelaar, Ria, additional, Driehuis, Else, additional, Leers, Mathie P G, additional, Sidorenkov, Grigory, additional, Tamminga, Menno, additional, van Kempen, Léon C, additional, and Schuuring, Ed, additional

Published
2022
Full Text
View/download PDF

35. The effect of treatment delay on quality of life and overall survival in head and neck cancer patients

Author

Schoonbeek, Rosanne C., primary, de Vries, Julius, additional, Bras, Linda, additional, Sidorenkov, Grigory, additional, Plaat, Boudewijn E. C., additional, Witjes, Max J. H., additional, van der Laan, Bernard F. A. M., additional, van den Hoek, Johanna G. M., additional, van Dijk, Boukje A. C., additional, Langendijk, Johannes A., additional, and Halmos, György B., additional

Published
2022
Full Text
View/download PDF

37. Influence of Frailty and Life Expectancy on Guideline Adherence and Outcomes in Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Prospective Pilot Study.

Author

Leus, Alet J.G., Haisma, Marjolijn S., Terra, Jorrit B., Sidorenkov, Grigory, Festen, Suzanne, Plaat, Boudewijn E.C., Halmos, György B., and Racz, Emoke

Subjects
LIFE expectancy, SQUAMOUS cell carcinoma, MOHS surgery, FRAILTY, OLDER patients, BASAL cell carcinoma, GERIATRIC assessment
Abstract

Background: Cutaneous squamous cell carcinoma is the second most common malignancy of the skin, often occurring in older patients and in the head and neck area (cSCCHN). Age, life expectancy, and frailty are not taken into consideration by current guidelines. Objectives: The objective of this study was to evaluate the influence of frailty and life expectancy on guideline deviation, treatment outcomes, and quality of life (QoL) after treatment in patients with cSCCHN. Methods: Patients with cSCCHN were prospectively included. A geriatric assessment was performed, including the Geriatric 8 (G8), Groningen Frailty Indicator, and Timed Up and Go test (TUG). The Lee index was used to predict a limited life expectancy, and the Adult Comorbidity Evaluation-27 was used as a comorbidity index. QoL was assessed by the Basal and Squamous cell carcinoma Quality of Life (BaSQoL) questionnaire at three time points. Results: Seventy-seven patients with cSCCHN were included. Frail patients had significantly more high-risk tumours. Guideline deviation occurred in 7.8% and was more common in patients who were frail (G8), with high-risk tumours (≥T2), with a limited life expectancy or an increased TUG. Guideline deviation did not lead more often to progression of disease in our study. No predictors for post-operative complications were found. BaSQoL subscores were very low at each time point and did not change significantly with time in the total group. Frail patients reported more fear of recurrence or new tumours 3 months after treatment, and less concern about other people's skin 6 months after treatment, compared to non-frail patients. Complication rate, gender, or guideline deviation did not affect any subscale scores. Conclusions: Assessment of frailty and life expectancy can guide physicians and patients in treatment decisions. Deviation from guidelines towards less aggressive treatment schedules can be considered in frail patients with a limited life expectancy, since it did not negatively affect short-term outcomes or QoL in patients with cSCCHN in our study. However, these results should be confirmed by other, larger prospective studies with a longer follow-up period. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

39. The Effect of Extended Participation Windows on Attendance at Cervical Cancer Screening

Author

Castañeda Vanegas, Kelly Melisa, primary, Sidorenkov, Grigory, additional, de Waard, Jolien, additional, Greuter, Marcel J.W., additional, van der Vegt, Bert, additional, Driesprong-de Kok, Inge, additional, Siebers, Albert G., additional, Vermeulen, Karin M., additional, Wisman, G. Bea A., additional, Schuuring, Ed, additional, and de Bock, Geertruida, additional

Published
2022
Full Text
View/download PDF

40. Performance of a deep learning-based lung nodule detection system as an alternative reader in a Chinese lung cancer screening program

Author

Cui, Xiaonan, primary, Zheng, Sunyi, additional, Heuvelmans, Marjolein A., additional, Du, Yihui, additional, Sidorenkov, Grigory, additional, Fan, Shuxuan, additional, Li, Yanju, additional, Xie, Yongsheng, additional, Zhu, Zhongyuan, additional, Dorrius, Monique D., additional, Zhao, Yingru, additional, Veldhuis, Raymond N.J., additional, de Bock, Geertruida H., additional, Oudkerk, Matthijs, additional, van Ooijen, Peter M.A., additional, Vliegenthart, Rozemarijn, additional, and Ye, Zhaoxiang, additional

Published
2022
Full Text
View/download PDF

41. Correction: Factors associated with SARS-COV-2 positive test in Lifelines.

Author

Sidorenkov, Grigory, Vonk, Judith M., Grzegorczyk, Marco, Cortés-Ibañez, Francisco O., and de Bock, Geertruida H.

Subjects
*CORRECTION factors, *CONTROL groups
Abstract

In Fig 1, the number of participants in the control group and the number of balanced datasets are incorrect. Please see the correct Fig 1 here.Graph: Fig 1 Overview of the procedure followed to reduce class imbalance (equalization strategy).* Continuous variables were rescaled to the interval between zero and one; AUC–Area Under the Curve.By Grigory Sidorenkov; Judith M. Vonk; Marco Grzegorczyk; Francisco O. Cortés-Ibañez and Geertruida H. de BockReported by Author; Author; Author; Author; Author [Extracted from the article]

Published
2024
Full Text
View/download PDF

42. Association of Deficits Identified by Geriatric Assessment With Deterioration of Health-Related Quality of Life in Patients Treated for Head and Neck Cancer

Author

de Vries, Julius, primary, Bras, Linda, additional, Sidorenkov, Grigory, additional, Festen, Suzanne, additional, Steenbakkers, Roel J. H. M., additional, Langendijk, Johannes A., additional, Witjes, Max J. H., additional, van der Laan, Bernard F. A. M., additional, de Bock, Geertruida H., additional, and Halmos, Gyorgy B., additional

Published
2021
Full Text
View/download PDF

43. Community-based lung cancer screening by low-dose computed tomography in China: First round results and a meta-analysis

Author

Li, Yanju, primary, Du, Yihui, additional, Huang, Yubei, additional, Zhao, Yingru, additional, Sidorenkov, Grigory, additional, Vonder, Marleen, additional, Cui, Xiaonan, additional, Fan, Shuxuan, additional, Dorrius, Monique D., additional, Vliegenthart, Rozemarijn, additional, Groen, Harry J.M., additional, Liu, Shiyuan, additional, Song, Fengju, additional, Chen, Kexin, additional, de Bock, Geertruida H., additional, and Ye, Zhaoxiang, additional

Published
2021
Full Text
View/download PDF

45. A contrast-enhanced-CT-based classification tree model for classifying malignancy of solid lung tumors in a Chinese clinical population

Author

Cui, Xiaonan, primary, Heuvelmans, Marjolein A., additional, Sidorenkov, Grigory, additional, Zhao, Yingru, additional, Fan, Shuxuan, additional, Groen, Harry J. M., additional, Dorrius, Monique D., additional, Oudkerk, Matthijs, additional, de Bock, Geertruida H., additional, Vliegenthart, Rozemarijn, additional, and Ye, Zhaoxiang, additional

Published
2021
Full Text
View/download PDF

47. Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study.

Author

Yihui Du, Sidorenkov, Grigory, Groen, Harry J. M., Heuvelmans, Marjolein A., Vliegenthart, Rozemarijn, Dorrius, Monique D., Timens, Wim, and de Bock, Geertruida H.

Abstract

Background: The relationship between smoking, airflow limitation, and lung cancer occurrence is unclear. This study aims to evaluate the relationship between airflow limitation and lung cancer, and the effect modification by smoking status. Methods: We included participants with spirometry data from Lifelines, a population-based cohort study from the Northern Netherlands. Airflow limitation was defined as FEV1/FVC ratio < 0.7. The presence of pathology-confirmed primary lung cancer during a median follow-up of 9.5 years was collected. The Cox regression model was used and hazard ratios (HR) with 95% confidence interval (95% CI) were reported. Adjusted confounders included age, sex, educational level, smoking, passive smoking, asthma status and asbestos exposure. The effect modification by smoking status was investigated by estimating the relative excess risk due to interaction (RERI) and the ratio of HRs with 95% CI. Results: Out of 98,630 participants, 14,200 (14.4%) had airflow limitation. In participants with and without airflow limitation, lung cancer incidence was 0.8% and 0.2%, respectively. The adjusted HR between airflow limitation and lung cancer risk was 1.7 (1.4-2.3). The association between airflow limitation and lung cancer differed by smoking status [former smokers: 2.1 (1.4-3.2), current smokers: 2.2 (1.5-3.2)] and never smokers [0.9 (0.4-2.1)]. The RERI and ratio of HRs was 2.1 (0.7-3.4) and 2.5 (1.0-6.5) for former smokers, and 4.6 (95% CI, 1.8-7.4) and 2.5 (95% CI, 1.0-6.3) for current smokers, respectively. Conclusions: Airflow limitation increases lung cancer risk and this association is modified by smoking status. Impact: Ever smokers with airflow limitation are an important target group for the prevention of lung cancer. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results